<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Immune thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo> (<z:chebi fb="0" ids="16039">ITP</z:chebi>) etiology is not clarified </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="16247">Phospholipid</z:chebi> antigen antibodies (aPls) occur in <z:chebi fb="0" ids="16039">ITP</z:chebi> patient sera </plain></SENT>
<SENT sid="2" pm="."><plain>We studied predictive values of elevated anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (anti-beta2-GP1) or anticardiolipin antibody (aCl) concentrations for secondary <z:chebi fb="0" ids="16039">ITP</z:chebi> detection, comparing levels with steroid therapy responsiveness in three groups of children and adolescents </plain></SENT>
<SENT sid="3" pm="."><plain>Participants' <z:hpo ids='HP_0003493'>antinuclear antibodies</z:hpo>, aCls (IgM, IgG) and anti-beta2-GPI (IgG) were assessed </plain></SENT>
<SENT sid="4" pm="."><plain>Significantly higher aCl (IgM), aCl (IgG) and anti-beta2-GPI (IgG) mean concentrations occurred in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="0" ids="16039">ITP</z:chebi> cases compared with <z:hpo ids='HP_0011009'>acute</z:hpo> or control cases </plain></SENT>
<SENT sid="5" pm="."><plain>Of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="0" ids="16039">ITP</z:chebi> cases, 77.8% showed elevated IgG aCl serum concentrations, and <z:hpo ids='HP_0000001'>all</z:hpo> presented increased IgG anti-beta2-GPI serum levels </plain></SENT>
<SENT sid="6" pm="."><plain>Significant positive correlation between <z:hpo ids='HP_0003237'>increased levels of IgG</z:hpo> anti-beta2-GPI and increased IgG aCl serum concentrations was determined; these increased IgG concentrations significantly correlated with steroid therapy resistance </plain></SENT>
<SENT sid="7" pm="."><plain>A total of 76.1% of <z:chebi fb="0" ids="16039">ITP</z:chebi> cases had positive aPls (<z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="0" ids="16039">ITP</z:chebi> cases, five <z:hpo ids='HP_0011009'>acute</z:hpo> <z:chebi fb="0" ids="16039">ITP</z:chebi> cases) </plain></SENT>
<SENT sid="8" pm="."><plain>Elevated aCl or anti-beta2-GPI serum IgG isotype concentrations occurred in <z:hpo ids='HP_0000001'>all</z:hpo> nine splenectomized <z:chebi fb="0" ids="16039">ITP</z:chebi> children with positive aPls (three showed increased IgM aCl levels) </plain></SENT>
<SENT sid="9" pm="."><plain>Follow-up of the initially studied <z:chebi fb="0" ids="16039">ITP</z:chebi> children (2000-2004) revealed 16.7% developed clinical and laboratory criteria of systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> erythrematosus (one <z:hpo ids='HP_0011009'>acute</z:hpo> <z:chebi fb="0" ids="16039">ITP</z:chebi> in remission, six <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="0" ids="16039">ITP</z:chebi>); elevated IgG aCl serum concentrations were found at study start in these seven cases, and six had increased anti-beta2-GPI </plain></SENT>
<SENT sid="10" pm="."><plain>IgG classes of both aCls and anti-beta2-GPI may be determinant cofactors for the developing risk of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> or <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> in <z:chebi fb="0" ids="16039">ITP</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>Great attention should be paid to both assays as predictors for steroid therapy response </plain></SENT>
</text></document>